Aree Pantusart

Summary

Publications

  1. ncbi Clinicopathologic analysis of women with synchronous primary carcinomas of the endometrium and ovary: 10- year experience from Chiang Mai University Hospital
    Jiraprapa Natee
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
    Asian Pac J Cancer Prev 7:234-8. 2006
  2. ncbi Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance
    Bandit Chumworathayi
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
    J Med Assoc Thai 88:1483-92. 2005
  3. ncbi Primary carcinoma of the fallopian tube: A clinicopathologic analysis of 27 patients
    Chumnan Kietpeerakool
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
    J Med Assoc Thai 88:1338-43. 2005
  4. ncbi Appropriate interval for repeat excision in women undergoing prior loop electrosurgical excision procedure for cervical neoplasia
    Chumnan Kietpeerakool
    Department of Obstetrics and Gynecology, Faculty of Medicine Chiang Mai University, Chiang Mai 50200, Thailand
    Asian Pac J Cancer Prev 8:379-82. 2007
  5. ncbi Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial
    Charuwan Tantipalakorn
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, 50200 Thailand
    J Med Assoc Thai 87:119-25. 2004

Collaborators

Detail Information

Publications5

  1. ncbi Clinicopathologic analysis of women with synchronous primary carcinomas of the endometrium and ovary: 10- year experience from Chiang Mai University Hospital
    Jiraprapa Natee
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
    Asian Pac J Cancer Prev 7:234-8. 2006
    ..The prognosis of patients with these tumors appears excellent...
  2. ncbi Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance
    Bandit Chumworathayi
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
    J Med Assoc Thai 88:1483-92. 2005
    ..CONCLUSION: Concurrent chemoradiation with weekly cisplatin regimen has more complete treatment rate and less delayed courses than that with three- weekly cisplatin among women with high-risk cervical cancer after surgery...
  3. ncbi Primary carcinoma of the fallopian tube: A clinicopathologic analysis of 27 patients
    Chumnan Kietpeerakool
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
    J Med Assoc Thai 88:1338-43. 2005
    ..To analyze the clinicopathologic features of women with primary fallopian tube carcinoma..
  4. ncbi Appropriate interval for repeat excision in women undergoing prior loop electrosurgical excision procedure for cervical neoplasia
    Chumnan Kietpeerakool
    Department of Obstetrics and Gynecology, Faculty of Medicine Chiang Mai University, Chiang Mai 50200, Thailand
    Asian Pac J Cancer Prev 8:379-82. 2007
    ..In conclusion, repeat LEEP could be safely performed 4-12 weeks after the first procedure without any impact on pathological specimen examination...
  5. ncbi Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial
    Charuwan Tantipalakorn
    Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, 50200 Thailand
    J Med Assoc Thai 87:119-25. 2004
    ..v. group. CONCLUSION: Oral ramosetron at a dosage of 0.2 mg is as effective as 0.3 mg of intravenous ramosetron in prevention of acute emesis in patients receiving 75 mg/m2 of cisplatin chemotherapy...